Intimation of receipt of approval of Listing of Equity Shares of Achyut Healthcare Limited on BSE Main Board Platform pursuant to Migration from BSE SME Platform.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.7 pts more than Nifty Microcap 250 and 5.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Achyut Healthcare Limited has received approval from BSE to migrate its equity shares from the BSE SME (Small and Medium Enterprise) platform to the BSE Main Board. The BSE approval letter was issued on January 1, 2026, and the shares will be traded on the Main Board starting Friday, January 2, 2026. With this migration, the company will now be subject to the full SEBI (LODR) Regulations, 2015, including stricter corporate governance norms applicable to main-board listed companies. The stock retains its BSE scrip code 543499.
For shareholders, this is generally a positive milestone as main-board listing typically improves visibility, liquidity, and access to a broader investor base. However, the company will now face higher compliance costs and stricter governance requirements compared to its earlier SME platform status.